IDEAYA Biosciences, Inc.
IDYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7,000 | $23,385 | $50,931 | $27,941 |
| % Growth | -70.1% | -54.1% | 82.3% | – |
| Cost of Goods Sold | $3,834 | $4,008 | $2,101 | $1,725 |
| Gross Profit | $3,166 | $19,377 | $48,830 | $26,216 |
| % Margin | 45.2% | 82.9% | 95.9% | 93.8% |
| R&D Expenses | $294,673 | $129,508 | $89,536 | $58,158 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $35,468 | $24,298 | $21,796 | $18,326 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $330,141 | $153,806 | $111,332 | $76,484 |
| Operating Income | -$326,975 | -$134,429 | -$62,502 | -$50,268 |
| % Margin | -4,671.1% | -574.9% | -122.7% | -179.9% |
| Other Income/Exp. Net | $52,498 | $21,468 | $3,847 | $506 |
| Pre-Tax Income | -$274,477 | -$112,961 | -$58,655 | -$49,762 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$274,477 | -$112,961 | -$58,655 | -$49,762 |
| % Margin | -3,921.1% | -483% | -115.2% | -178.1% |
| EPS | -3.36 | -1.96 | -1.42 | -1.41 |
| % Growth | -71.4% | -38% | -0.7% | – |
| EPS Diluted | -3.36 | -1.96 | -1.42 | -1.41 |
| Weighted Avg Shares Out | 81,678 | 57,520 | 41,445 | 35,252 |
| Weighted Avg Shares Out Dil | 81,678 | 57,520 | 41,445 | 35,252 |
| Supplemental Information | – | – | – | – |
| Interest Income | $52,498 | $21,468 | $3,847 | $506 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3,834 | $4,008 | $2,101 | $1,725 |
| EBITDA | -$270,643 | -$108,953 | -$56,554 | -$48,037 |
| % Margin | -3,866.3% | -465.9% | -111% | -171.9% |